Novel molecular targets for atrial fibrillation therapy

D Dobrev, L Carlsson, S Nattel - Nature reviews Drug discovery, 2012 - nature.com
Atrial fibrillation is the most common type of cardiac arrhythmia, and is responsible for
substantial morbidity and mortality in the general population. Current treatments have …

[PDF][PDF] The molecular pathophysiology of atrial fibrillation

S Nattel, J Heijman, N Voigt… - … : From cell to bedside, 2018 - researchgate.net
The Molecular Pathophysiology of Atrial Fibrillation Page 1 1 The Molecular
Pathophysiology of Atrial Fibrillation Stanley Nattel,1, 2,4 Jordi Heijman,3 Niels Voigt,4 …